Related Experiment Videos
[The meconium ileus equivalent in mucoviscidosis]
Klinische Padiatrie
|September 1, 1983
Summary
Meconium ileus equivalent (MIE) in cystic fibrosis (CF) patients is often preventable. Rigorous medical management of pancreatic insufficiency and mucolytics can typically prevent and treat MIE, reserving surgery for severe cases.
Area of Science:
- Pediatrics
- Gastroenterology
- Pulmonology
Context:
- Meconium ileus equivalent (MIE) is a frequent complication in cystic fibrosis (CF) patients, particularly with increasing age.
- This study analyzes the course of 11 pediatric patients with MIE treated at a tertiary care center over 15 years.
Purpose:
- To evaluate the management and outcomes of MIE in pediatric CF patients.
- To determine the efficacy of medical versus surgical interventions for MIE.
- To identify factors contributing to chronic or refractory MIE.
Summary:
- Nine out of eleven patients with MIE were successfully managed with medical treatment alone.
- One infant required surgery with no recurrence, while a 26-year-old patient needed an ileostomy for a chronic, severe course.
- Four patients experienced chronic MIE, potentially due to inadequate medical management, highlighting the importance of consistent treatment.
Impact:
- Highlights that MIE is a preventable complication in cystic fibrosis.
- Emphasizes the critical role of rigorous medical management, including pancreatic enzyme replacement and mucolytics, in preventing and treating MIE.
- Suggests that surgical intervention should be reserved for refractory or life-threatening cases of MIE.